Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Open Access
- 3 March 2010
- journal article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 7 (1-3) , 175-179
Abstract
Background: Leucine-rich repeat kinase 2 (LRRK2) has emerged as the most prevalent genetic cause of Parkinson’s disease (PD) among Caucasians. Patients carrying an LRRK2 mutation display significant variability of clinical and pathologic phenotypes across and within affected families. Methods: Herein, we review available clinical and pathologic data on patients with an LRRK2 mutation who have come to autopsy. Results: Thirty-eight patients have been reported who presented clinically with PD; parkinsonism with resistance to levodopa, supranuclear gaze palsy, or autonomic dysfunction; or tremor and dementia. Pathology showed typical PD-type Lewy body disease (LBD) in most patients, whereas in others there was ‘pure’ nigral degeneration (one with TDP-43-positive inclusions), diffuse LBD, or tau-, α-synuclein- or ubiquitin-positive pathology reminiscent of progressive supranuclear gaze palsy, multisystem atrophy, and frontotemporal dementia with ubiquitin-positive inclusions. Conclusions: Such clinical and pathologic variability suggests Lrrk2 acts upstream from other proteins implicated in neurodegeneration. Specific mutations may be associated with alternative progressive supranuclear gaze palsy-like or ‘pure’ nigral degeneration phenotypes. A different effect on Lrrk2 kinase activity may play a role in such heterogeneity.Keywords
This publication has 25 references indexed in Scilit:
- Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomesParkinsonism & Related Disorders, 2009
- LRRK2 and neurodegenerationActa Neuropathologica, 2009
- CORTICOBASAL SYNDROME AND PRIMARY PROGRESSIVE APHASIA AS MANIFESTATIONS OF LRRK2 GENE MUTATIONSNeurology, 2008
- Screening for the LRRK2 G2019S and codon-1441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degenerationJournal of the Neurological Sciences, 2008
- Corticobasal syndrome and primary progressive aphasia as manifestations ofLRRK2gene mutationsNeurology, 2008
- Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusionsActa Neuropathologica, 2006
- LRRK2 mutations on Crete: R1441H associated with PD evolving to PSPNeurology, 2006
- A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwanneurogenetics, 2006
- Lrrk2 and Lewy body diseaseAnnals of Neurology, 2006
- A common LRRK2 mutation in idiopathic Parkinson's diseaseThe Lancet, 2005